News | Lung Cancer | October 05, 2017

CompleWare and Vida Announce Joint Marketing Agreement for Respiratory Trials

Vida will combine its pulmonary imaging software suite with CompleWare’s application for clinical trial data capture and management

October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a high-end pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging.

CompleWare software and contract research organization (CRO) services will facilitate complete respiratory development programs. This will provide specialized experts to support global respiratory trials. VIDA and CompleWare will provide precision lung imaging informatics, delivered through core lab imaging services (Precision Services) and interactive software (VIDA|vision). This solution spans the care cycle, from detection through treatment across a range of pulmonary diseases: COPD (including severe emphysema, chronic bronchitis), lung cancer and asthma.

The CompleClinical application from CompleWare is a comprehensive eClinical solution for clinical trial data capture and management. The VIDA|vision pulmonary suite of software and services provides full breadth and depth of analysis, empowering chest physicians with advanced, quantitative information to help inform care decisions.

For more information: www.compleware.com, www.vidadiagnostics.com

Related Content

This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

This chest X-ray of a patient being treated for e-cigarette or vaping-associated lung injury shows lung opacities, densities and whitish cloud-like areas which are typically seen with unusual pneumonias, fluid in lungs or lung inflammation. Image courtesy of Intermountain Healthcare

News | Clinical Trials | November 08, 2019

Best Practice Treatment Guidelines Help Doctors Identify, Treat Vaping-associated Lung Injuries

November 8, 2019 — As the outbreak of lung injuries and deaths associated with e-cigarettes, or...

Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting from the use of electronic cigarettes (e-cigarettes), or “vaping.”

Image by Lindsay Fox from Pixabay

News | Computed Tomography (CT) | November 06, 2019

Radiology: Cardiothoracic Imaging Publishes Special Report on Vaping

November 6, 2019 — Radiology: Cardiothoracic Imaging has published a special report on lung injury resulting

LungPrint Discovery offers fully automatic radiological metrics and unique, time-saving airway visualizations

News | Advanced Visualization | October 29, 2019

Vida Partners With TeraRecon for Distribution of AI-powered Lung Analysis

October 29, 2019 — VIDA Diagnostics, Inc.

Technology | Computed Tomography (CT) | September 26, 2019

FDA Clears Modules of AI-Rad Companion Chest CT From Siemens Healthineers

The U.S. Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent...

Virtual Reality 3-D Models Help Yield Better Surgical Outcomes

Joseph Shirk, M.D., of UCLA with the virtual reality headset. Image courtesy of UCLA Jonsson Comprehensive Cancer Center

News | Virtual and Augmented Reality | September 25, 2019

Virtual Reality 3-D Models Help Yield Better Surgical Outcomes

A UCLA-led study has found that using three-dimensional virtual reality (VR) models to prepare for kidney tumor...

News | Lung Cancer | September 18, 2019

Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...

3D Systems Earns Additional FDA Clearance for D2P Medical 3-D Printing Software

3D Systems’ D2P FDA-cleared software allows clinicians to 3-D-print diagnostic patient-specific anatomic models. Image courtesy of 3D Systems.

Technology | Medical 3-D Printing | September 12, 2019

3D Systems Earns Additional FDA Clearance for D2P Medical 3-D Printing Software

3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software...

Technology | X-Ray | September 12, 2019

FDA Clears GE Healthcare's Critical Care Suite Chest X-ray AI

GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a...

News | Neuro Imaging | August 29, 2019

Delaware Imaging Network Now Offers NeuroQuant Brain Imaging MRI Software

Delaware Imaging Network (DIN), Delaware’s largest network of outpatient medical imaging centers, has added NeuroQuant...

Smoldering Spots in the Brain May Signal Severe MS

NIH researchers found that dark rimmed spots representing ongoing, “smoldering” inflammation, may be a hallmark of more disabling forms of multiple sclerosis. Image courtesy of Reich lab, NIH/NINDS.

News | Neuro Imaging | August 22, 2019

Smoldering Spots in the Brain May Signal Severe MS

Aided by a high-powered brain scanner and a 3-D printer, National Institutes of Health (NIH) researchers peered inside...